Breast cancer	BC
Neoadjuvant therapy	NAT
microRNAs	miRNAs
Pathologic complete response	pCR
Triple-negative BC	TNBC
3′-untranslated region	3′-UTR
High-density lipoproteins	HDL
Trichorhinophalangeal syndrome type 1 protein	TRPS1
Epithelial-to-mesenchymal transition	EMT
Multidrug resistance protein 1	MRP-1
Estrogen receptor 1	ESR1
Circulating tumor cells	CTCs
Progesterone receptor	PGR
Estrogen receptor	ER
Event-free survival	EFS
BC stem cell	BCSC
neoadjuvant polychemotherapy	NPCT
Mitofusin-2	MFN2
Adriamycin	ADR
Clinical complete response	cCR
Protein inhibitor of activated signal transducer and activator of transcription 4	PIAS4
Miller–Payne	MP
Programmed cell death 4	PDCD4
Invasive ductal carcinoma	IDC